Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-005518
Filing Date
2022-04-15
Accepted
2022-04-15 16:09:35
Documents
7
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20220608xpre14a.htm PRE 14A 1891510
2 GRAPHIC tmb-20220608xpre14a002.jpg GRAPHIC 3678
3 GRAPHIC tmb-20220608xpre14a003.jpg GRAPHIC 1695
4 GRAPHIC tmb-20220608xpre14a001.jpg GRAPHIC 14201
5 GRAPHIC tmb-20220608xpre14a018.jpg GRAPHIC 5660
6 GRAPHIC tmb-20220608xpre14a004.jpg GRAPHIC 62198
7 GRAPHIC tmb-20220608xpre14a007.jpg GRAPHIC 53257
  Complete submission text file 0001558370-22-005518.txt   2087330
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35969 | Film No.: 22830141
SIC: 2834 Pharmaceutical Preparations